← All EvidenceDirectTrent Middleton โ Direct Trent Middleton Katherine Trefz CrossTrent Middleton โ Cross Trent Middleton Robert S. Leach
Demonstratives
Defense Exhibit 10685
Contains calculations from customer-receipt and option or stock-proceeds rows in Exhibit 5172. It was also described in closing argument as a Theranos record reflecting more than $200 million in deferred revenue.
Also known as (3)
- Exhibit 10685
- Option/stock proceeds summary
- Theranos record reflecting more than $200 million in deferred revenue